Skip to main content

Patanase FDA Approval History

FDA Approved: Yes (First approved April 15, 2008)
Brand name: Patanase
Generic name: olopatadine hydrochloride
Dosage form: Nasal Spray
Company: Alcon, Inc.
Treatment for: Allergic Rhinitis

Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Development timeline for Patanase

Apr 16, 2008Approval Alcon's Patanase Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Oct 11, 2007Alcon Amends NDA for Patanase Nasal Spray

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.